Novel method for determination of substance P levels in unextracted human plasma by using acidification

Clinical and Vaccine Immunology

Volumn 16, Issue 4, 2009, Pages 594-596

  Campbell, Donald E ^a,b   Bruckner, Paula ^a   Tustin, Nancy B ^a   Tustin, Richard ^a   Douglas, Steven D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; SUBSTANCE P; TACHYKININ;

ACIDIFICATION; ARTICLE; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PH MEASUREMENT; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROGEN-ION CONCENTRATION; PLASMA; SUBSTANCE P;

EID: 64549119727     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00406-08     Document Type: Article

References (28)

1. Anichini, M., S. Cesaretti, M. Lepori, S. Maddali Bongi, M. Maresca, and M. Zoppi. 1997. Substance P in the serum of patients with rheumatoid arthritis. Rev. Rhum. Engl. Ed. 64:18-21.
2. Bondy, B., T. C. Baghai, C. Minov, C. Schule, J. M. Schwarz, P. Zwanzger, R. Rupprecht, and J.-H. Moller. 2003. Substance P serum levels are increased in major depression: preliminary results. Biol. Psychiatry 53:538-542.
3. Bost, K. L. 2004. Tachykinin-mediated modulation of the immune response. Front. Biosci. 9:3331-3332.
4. Campbell, D. E., N. Raftery, R. Tustin III, N. B. Tustin, M. L. DeSilvio, A. Cnaan, P. P. Aye, A. A. Lackner, and S. D. Douglas. 2006. Measurement of plasma-derived substance P: biological, methodological, and statistical considerations. Clin. Vaccine Immunol. 13:1197-1203.
5. Clark, J. W., P. D. Senanayake, G. D. Solomon, and C. Gallagher. 1994. Substance P: correlation of CSF and plasma levels. Headache 34:261-264.
6. Corbally, N., D. Powell, and K. F. Tipton. 1990. The binding of endogenous and exogenous substance-P in human plasma. Biochem. Pharmacol. 39: 1161-1166.
7. Douglas, S. D., A. Cnaan, K. G. Lynch, T. Benton, H. Zhao, D. R. Gettes, and D. L. Evans. 2008. Elevated substance P levels in HIV-infected women in comparison to HIV-negative women. AIDS Res. Hum. Retrovir. 24:375-378.
8. Douglas, S. D., W.-Z. Ho, D. R. Gettes, A. Cnaan, H. Zhao, J. Leserman, J. M. Petitto, R. N. Golden, and D. L. Evans. 2001. Elevated substance P levels in HIV-infected men. AIDS 15:2043-2045.
9. Faulhaber, H. D., R. Rathsack, G. Rostock, V. Homuth, D. Pfeiffer, E. Naumann, W. Hartrodt, R. C. Gorne, and P. Oehme. 1983. Evidence of decreased plasma substance P levels in human essential hypertension and influence of prazosin treatment. Biomed. Biochim. Acta 42:1019-1025.
10. Fehder, W. P., W.-Z. Ho, D. E. Campbell, W. W. Tourtellotte, L. Michaels, J. R. Cutilli, M. Uvaydova, and S. D. Douglas. 1998. Development and evaluation of a chromatographic procedure for partial purification of substance P with quantitation by an enzyme immunoassay. Clin. Diagn. Lab. Immunol. 5:303-307.
11. Fehder, W. P., J. Sachs, M. Uvaydova, and S. D. Douglas. 1997. Substance P as an immune modulator of anxiety. Neuroimmunomodulation 4:42-48.
12. Fernandez-Rodriguez, C. M., J. Prieto, J. Quiroga, J. M. Zozoya, A. An-drade, M. Nunez, B. Sangro, and J. Penas. 1995. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology 21:35-40.
13. Ho, W.-Z., and S. D. Douglas. 2004. Substance P and neurokinin-1 receptor modulation of HIV. Neuroimmunology 157:48-55.
14. Kramer, M. S., N. Cutler, J. Feighner, R. Shrivastava, J. Carman, J. J. Sramek, S. A. Reines, G. Liu, D. Snavely, E. Wyatt-Knowles, J. J. Hale, S. G. Mills, M. MacCoss, C. J. Swain, T. Harrison, R. G. Hill, F. Hefti, E. M. Scolnick, M. A. Cascieri, G. G. Chicchi, S. Sadowski, A. R. Williams, L. Hewson, D. Smith, E. J. Carlson, R. J. Hargreaves, and N. M. J. Rupniak. 1998. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640-1645.
15. Reference deleted.
16. Mantyh, C. R., T. S. Gates, R. P. Zimmerman, M. L. Welton, E. P. Passaro, Jr., S. R. Vigna, J. E. Maggio, L. Kruger, and L. W. Mantyh. 1988. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc. Natl. Acad. Sci. USA 85:3235-3239.
17. Marshall, K. W., B. Chiu, and R. D. Inman. 1990. Substance P and arthritis: analysis of plasma and synovial fluid. Arthritis Rheum. 33:87-90.
18. McGillis, J. P., M. Mitsuhashi, and D. G. Payan. 1990. Immunomodulation by tachykinin neuropeptides. Ann. N. Y. Acad. Sci. 594:85-94.
19. 1 receptor have a role in depression and anxiety? Curr. Pharm. Des. 11:1529-1547.
20. Michaels, L. A., K. Ohene-Frempong, H. Zhao, and S. D. Douglas. 1998. Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood 92:3148-3151.
21. Nicoll, R. A., C. Schenker, and S. E. Leeman. 1980. Substance P as a neurotransmitter candidate. Annu. Rev. Neurosci. 3:227-268.
22. Otsuka, M., and T. Takahashi. 1977. Putative peptide neurotransmitters. Annu. Rev. Pharmacol. Toxicol. 17:425-439.
23. Otsuka, M., and K. Yoshioka. 1993. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:229-308.
24. Palma, C., and C. A. Maggi. 2000. The role of tachykinins via NK1 receptors in progression of human gliomas. Life Sci. 67:985-1001.
25. Rissler, K. 1995. Sample preparation, high-performance liquid chromato-graphic separation and determination of substance P-related peptides. J. Chromatogr. B 665:233-270.
26. Rupniak, N. M. J. 2002. New insights into the antidepressant actions of substance P (NK-1 receptor) antagonists. Can. J. Physiol. Pharmacol. 80: 489-494.
27. Singh, D., D. D. Joshi, M. Hameed, J. Qian, P. Gascon, B. P. Maloof, A. Mosenthal, and P. Rameshwar. 2000. Increased expression of preprotachy-kinin-1 and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. Proc. Natl. Acad. Sci. USA 97:388-393.
28. Tripp, R. A., A. Barskey, L. Goss, and L. J. Anderson. 2002. Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection. J. Neuroimmunol. 129:141-153.